I-2 IMMUNOHISTOCHEMISTRY AND CONFOCAL TECHNIQUES C.M. Brown
McGill Univ. Imaging Facility, Monteal, QC, Canada Purpose: To provide an introduction to Immunohistochemistry and Confocal Imaging Techniques Methods: How to perform imaging of immunohistochemistry samples either with a colour camera or blue, green and red filter sets. How to generate high quality confocal images and to separate fluorescence dyes with similar fluorescence spectra. How to remove specimen auto-fluorescence from the signal from specific fluorescence probes. Results: Proper camera colour balance is required to generate suitable images of immunohistological samples. Three images using blue, green and red filters can be generated using a monochrome camera and overlayed in image processing software in order to image Immunohistological samples without the need for a colour camera. With the proper imaging settings high quality confocal images can be generated from fluorescent samples.
Spectral imaging can be used to separate dyes of similar colour and to remove specimen auto-fluorescence. Conclusions: Following this presentation attendees should have a clear idea of the main aspects to keep in mind when performing brightfield or confocal imaging.
I-3 STRATEGIES TO USE MODERN IMAGING TECHNOLOGIES TO EVALUATE PATIENTS WITH OA F.M. Cicuttini
Monash Univ., Melbourne, Australia Purpose: The radiographic examination of joints is useful in the diagnosis of osteoarthritis (OA) and has enabled significant progress to be made in our understanding of risk factors for OA. However new imaging modalities provide novel opportunities to investigate the pathogenesis of OA through examining the whole joint. The aim of this presentation is to examine current strategies using modern imaging technologies in the evaluation of patients with OA and to consider the potential impact of these new approaches. OA is a disease of the whole joint. By using improved, non-invasive techniques such as magnetic resonance imaging (MRI) to visualise the whole joint, it is now possible to examine the relative role of different joint structures such as cartilage, bone, menisci, synovium and ligaments simultaneously on the symptomatology and progression of OA. Recent work demonstrates that knee OA is the result of multiple, cumulative changes in joint structure occurring in the apparently healthy, asymptomatic state, which progress until clinical disease presents itself. The use of MRI, a sensitive and non-invasive tool, has enabled the examination of these early changes of OA, prior to radiographic disease, through to the joint with end stage disease. This shows that our current definitions of radiographic tibiofemoral OA fall on the continuum from health to disease, with approximately 10% of articular knee cartilage lost before radiological disease is detected. Since OA is recognised as a multifactorial disease, using a sensitive examination of joint structure, provides opportunities to examine new hypotheses in the pathogenesis of OA. Identifying early changes may provide novel targets for the prevention and treatment of knee OA. At an individual level, they may also help identify those at risk of OA who may benefit from early lifestyle modification. Although much of the current wok has focussed on MRI, other modalities such as ultrasound, scintigraphy, and CT are also being used in the evaluation of patients with OA and provide complementary information.
I-4 NEW APPROACHES TO MEASUREMENT OF OUTCOMES TO ASSESS EFFICACY OF OSTEOARTHRITIS TREATMENT: THE OARSI-OMERACT INITIATIVE

M. Dougados
René Descartes Univ., Paris, France Purpose: In order to propose a set of criteria for considering total articular replacement (e.g. medical treatment failure) to be used as an end-point in clinical trials evaluating potential disease modifying drugs, a joint OARSI-OMERACT initiative is aiming at S1
